Search results
EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid
Pharmaceutical Technology· 3 days agoA long-acting antibody, sipavibart has been designed to neutralise the spike protein interaction...
Sanofi reports findings from Phase II relapsing MS treatment trial
Clinical Trials Arena· 4 days agoSanofi has reported the latest data from a Phase II clinical trial of a cluster of differentiation...
Dianthus reveals preclinical data for its Phase II neuromuscular candidate
Pharmaceutical Technology· 3 days agoDNTH103 is a fully human IgG4 monoclonal antibody that inhibits the active form of C1s, a protein...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 4 days agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...
Eisai and Bristol Myers cancel cancer ADC deal
BioPharma Dive· 3 days agoThe Japan-based drugmaker said its U.S. partner’s “portfolio prioritization efforts” led to the termination. It will refund part of an upfront payment.
French Stocks Boost Europe as Investors Buy the Dip; UK Gains
Livemint· 5 hours agoFrench stocks outperformed on Thursday again, boosting the broader market as Morgan Stanley recommended investors to buy the country’s stocks ahead of the second round of elections. UK’s index ...
French and UK Stocks Outshine European Peers Ahead of Elections
Livemint· 5 hours agoFrench stocks outperformed on Thursday, boosting the broader market, as polls showed Marine Le Pen’s National Rally and its allies would fall well short of an absolute majority in Sunday’s French ...
Modernizing cell culture processes for the next wave of genomic medicine
Pharmaceutical Technology· 3 days agoWith genomic medicine gaining clinical momentum, developers are looking for more robust ways to...
EAN 2024: anti-CGRPs more effective than onabotulinumtoxinA in chronic migraine prevention in real...
Pharmaceutical Technology· 2 days agoOn 30 June 2024, at the tenth Congress of the European Academy of Neurology (EAN) 2024, during an...
Tracon mulls strategic options after sarcoma drug fails Phase II trial
Clinical Trials Arena· 2 days agoTracon investigated envafolimab as a treatment for two types of advanced or metastasised soft tissue...